Evaluation and Comparison of the Therapeutic effect of Turpentine Van Oil and Van Raw Juice in patients with Peptic ulcer

Evaluation and Comparison of the Therapeutic effect of Turpentine Van Oil and Van Raw Juice (Pistacia Atlantica sub. Cordica) in patients with Peptic ulcer

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240702062310N1

Enrollment

275

Registered

2024-07-25

Start date

2024-08-21

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic Ulcer. Peptic ulcer, site unspecified

Interventions

Intervention 1: Intervention group1: Usual treatment for peptic ulcer + two capsules of turpentine Van (0.5 milliliter) once a day (provided by Van factory in Kurdistan). Intervention 2: Intervention

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with peptic ulcer

Exclusion criteria

Exclusion criteria: Receiving previous treatment for Helicobacter pylori and peptic ulcer Constantly taking NSAIDS Cancer pregnancy cerebral arteriosclerosis cardiac disease Liver Disease renal disease

Design outcomes

Primary

Measure	Time frame
Ulcer size. Timepoint: Before starting treatment, one month after starting treatment, two months after starting treatment. Method of measurement: endoscopy.	—

Secondary

Measure	Time frame
Ulcer depth. Timepoint: Before the start of treatment (beginning of the study), one month after the start of treatment, two months after the start of treatment. Method of measurement: endoscopy.;Ulcer induration. Timepoint: Before the start of treatment (beginning of the study), one month after the start of treatment, two months after the start of treatment. Method of measurement: endoscopy.;Clinical Symptom. Timepoint: before the start of treatment (beginning of the study), every one week after the start of treatment until the end of treatment. Method of measurement: Check list.;Adverse effect. Timepoint: before the start of treatment (beginning of the study), every one week after the start of treatment until the end of treatment. Method of measurement: Check list.	—

Measure

Time frame

Ulcer depth. Timepoint: Before the start of treatment (beginning of the study), one month after the start of treatment, two months after the start of treatment. Method of measurement: endoscopy.;Ulcer induration. Timepoint: Before the start of treatment (beginning of the study), one month after the start of treatment, two months after the start of treatment. Method of measurement: endoscopy.;Clinical Symptom. Timepoint: before the start of treatment (beginning of the study), every one week after the start of treatment until the end of treatment. Method of measurement: Check list.;Adverse effect. Timepoint: before the start of treatment (beginning of the study), every one week after the start of treatment until the end of treatment. Method of measurement: Check list.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHakim Khodaei

Sanandaj University of Medical Sciences

hakim.khodaei@muk.ac.ir+98 87 3371 7226

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026